DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vaseretic (Enalapril / Hydrochlorothiazide) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Vaseretic (Enalapril / Hydrochlorothiazide) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (8)
Life Threatening Events (1)

Reports by Reaction Type

Renal Failure Acute (4)Fall (2)Dehydration (2)Asthenia (2)Rhabdomyolysis (1)Hypoglycaemia (1)Disorientation (1)Headache (1)Lactic Acidosis (1)Pyrexia (1)Erythema (1)Auricular Swelling (1)

Possible Vaseretic side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-04-27

Patient: 64 year old male

Reactions: Auricular Swelling, Angioedema, Skin Ulcer, Otorrhoea, Pyrexia, Erythema, Blood Glucose Increased

Drug(s) suspected as cause:
Vaseretic
    Dosage: 1 df;qd
    Indication: Hypertension

Nasonex
    Dosage: 50 mcg;nas
    Indication: Acute Sinusitis
    Start date: 2012-02-20
    End date: 2012-02-20

Other drugs received by patient: Lantus; Aspirin; Novorapid; Simvastatin



Possible Vaseretic side effects in 82 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-08

Patient: 82 year old female

Reactions: Vomiting, Rhabdomyolysis, Hyponatraemia, Disorientation, Fall, Burns Second Degree, Diarrhoea, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Polyethylene Glycol
    Dosage: po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-12-07

Depaide (Valpromide)
    Dosage: 500 mg, bid, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-12-07

Mirtazapine
    Dosage: 15 mg, qd, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-12-07

Modopar (Madopar 00349201 / )
    Dosage: 3 df, qd
    Indication: Product Used FOR Unknown Indication

Domperidone (Mfr Unknown) (Dokmperidone)
    Dosage: prn, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Vaseretic
    Dosage: 1 df, qd
    Indication: Product Used FOR Unknown Indication
    End date: 2011-12-07

Esomeprazole (Mfr Unknown) (Esomeprazole)
    Dosage: 20 mg, qd
    Indication: Product Used FOR Unknown Indication
    End date: 2011-12-07

Tramadol (Unknown Mfr) (Tramadol / 00599201 / )
    Dosage: prn po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-12-06

Other drugs received by patient: Urbanyl



Possible Vaseretic side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-07

Patient: 60 year old female, weighing 90.0 kg (198.0 pounds)

Reactions: Cardio-Respiratory Arrest, Hyperkalaemia, Hypoglycaemia, Coma, Lactic Acidosis, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Diclofenac Sodium
    Administration route: Oral
    End date: 2012-01-07

Vaseretic
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-01-07

Furosemide
    Administration route: Oral
    Start date: 2012-01-02
    End date: 2012-01-07

Lercanidipine
    Administration route: Oral
    End date: 2012-01-07

Furosemide
    Administration route: Oral
    End date: 2012-01-01

Metformin Hydrochloride
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2012-01-07

Januvia
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2012-01-07

Valsartan
    Administration route: Oral
    End date: 2012-01-07

Potassium Chloride
    Administration route: Oral
    End date: 2012-01-07



Possible Vaseretic side effects in male

Reported by a physician from Italy on 2012-03-05

Patient: male

Reactions: Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tenoretic 100
    Dosage: 50 mg/12.5 mg 1 df daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-12-01

Vaseretic
    Dosage: 20 mg/12.5 mg, 1 df daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-12-01
    End date: 2012-02-10

Lasix
    Administration route: Oral
    Start date: 2011-12-01
    End date: 2012-02-09

Lasix
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2012-01-01
    End date: 2012-02-09

Other drugs received by patient: Seleparina; Diazepam



Possible Vaseretic side effects in male

Reported by a physician from Italy on 2012-03-01

Patient: male

Reactions: Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tenoretic 100
    Dosage: 50 mg/12.5 mg tablets daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-12-01

Lasix
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2012-01-01
    End date: 2012-02-09

Vaseretic
    Dosage: 20 mg/12.5 mg tablets daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-12-01
    End date: 2012-02-10

Other drugs received by patient: Seleparina; Diazepam



Possible Vaseretic side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-01

Patient: 50 year old male

Reactions: Renal Failure, Dehydration, Underdose, Intestinal Obstruction, Pancreatic Enzymes Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rilmenidine
    Administration route: Oral
    End date: 2011-08-09

Allopurinol
    Administration route: Oral
    End date: 2011-08-09

Januvia
    Administration route: Oral
    End date: 2011-08-09

Oxycodone HCL
    Start date: 2011-07-13
    End date: 2011-08-09

Repaglinide
    Administration route: Oral
    Start date: 2011-08-19

Lercanidipine Hydrochloride
    Administration route: Oral
    End date: 2011-08-09

Repaglinide
    Administration route: Oral
    End date: 2011-08-09

Betaxolol HCL
    Administration route: Oral
    End date: 2011-08-09

Vaseretic
    Administration route: Oral
    End date: 2011-08-09

Atorvastatin Calcium
    Administration route: Oral
    End date: 2011-08-09

Other drugs received by patient: Mycophenolate Mofetil; Tacrolimus; Prednisone



Possible Vaseretic side effects in male

Reported by a consumer/non-health professional from United States on 2012-01-17

Patient: male

Reactions: Renal Disorder

Drug(s) suspected as cause:
Vaseretic
    Dosage: unk

Lasix
    Dosage: unk

Norvasc
    Dosage: unk



Possible Vaseretic side effects in female

Reported by a consumer/non-health professional from United States on 2011-12-06

Patient: female, weighing 118.0 kg (259.6 pounds)

Reactions: Blood Pressure Increased, Headache, Fall, Injection Site Erythema, Joint Swelling, Balance Disorder, Dehydration, Asthenia, Escherichia Infection, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rebif
    Start date: 2011-08-18

Vaseretic
    Indication: Hypertension
    End date: 2011-11-01

Rebif
    Indication: Multiple Sclerosis
    Start date: 2011-05-27

Other drugs received by patient: Acetaminophen

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017